LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com
Jess Armine, DC, RN: Introduction to Functional Medicine Part 1 (LDN, low dose naltrexone)
Jess Armine, DC, RN: Introduction to Functional Medicine Part 1 (LDN, low dose naltrexone) Dr. Jess Armine gives an Introduction to Functional Medicine and why Nutrition is so important to Chronically ill Patients
Jess Armine, DC, RN: Introduction to Functional Medicine Part 2 (LDN, low dose naltrexone)
Jess Armine, DC, RN: Introduction to Functional Medicine Part 2 (LDN, low dose naltrexone) Dr. Jess Armine gives an Introduction to Functional Medicine and why Nutrition is so important to Chronically ill Patients
Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (Abstract)
Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 Eur Heart J Cardiovasc Pharmacother 18 February 2022 https://pubmed.ncbi.nlm.nih.gov/35179184/ Coronavirus disease 2019 (COVID-19) is characterized by striking dysregulation of the immune system, with evidence of hyperinflammation, an impaired induction of interferons, and delayed adaptive immune responses. In addition to dysfunctional immune responses, […]
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone (News)
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone GlobalNewswire 27 April 2022 https://www.globenewswire.com/news-release/2022/04/27/2430707/0/en/Statera-Biopharma-and-Immune-Therapeutics-Inc-Announce-Strategic-Agreement-for-Rights-to-Low-Dose-Naltrexone.html Statera Biopharma, a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced an agreement with Immune Therapeutics to sell Statera’s rights to any product containing met-enkephalin or low-dose naltrexone as […]
Can Low Dose Naltrexone (LDN) be taken indefinitely?
Discussing Low-Dose Naltrexone with Sajad Zalzala (News)
Discussing Low-Dose Naltrexone with Sajad Zalzala Lifespan.io 20 April 2022 https://www.lifespan.io/news/discussing-low-dose-naltrexone-with-sajad-zalzala/ This drug, known for curbing addictions, has shown other benefits in some patients. Dr. Zalzala responds to questions on the use of low dose naltrexone (LDN).